Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Warsaw - Delayed Quote PLN

NEUCA S.A. (NEU.WA)

748.00
+16.00
+(2.18%)
As of 2:04:15 PM GMT+2. Market Open.
Loading Chart for NEU.WA
  • Previous Close 732.00
  • Open 741.00
  • Bid 745.00 x --
  • Ask 749.00 x --
  • Day's Range 735.00 - 749.00
  • 52 Week Range 636.00 - 969.00
  • Volume 346
  • Avg. Volume 1,920
  • Market Cap (intraday) 3.403B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 21.02
  • EPS (TTM) 35.58
  • Earnings Date May 22, 2025
  • Forward Dividend & Yield 14.50 (1.98%)
  • Ex-Dividend Date Jun 12, 2024
  • 1y Target Est 914.00

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors, and patients. It provides medical care services, including prevention, diagnostics, treatment, and complementary services; and financing services, such as insurance, subscriptions, occupational medicine, preventive and medicine programmes, FFS, NFZ, public, private, and corporate payer services. In addition, the company offers TPA services, remote consultations, stationary visits, diagnostic tests, and occupational medicine services; operates a medical helpline and medical facilities; and offers medicine through apteline.pl, an e-commerce medical ordering site. Further, it engages in running clinical trials in the field of outsourcing clinical research and conducting clinical research centres; provision of insurance activities, including health insurance products. It also provides advertising and marketing services to pharmaceutical market entities; and logistics services for pharmaceutical manufacturers. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.

www.neuca.pl

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NEU.WA

View More

Performance Overview: NEU.WA

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

NEU.WA
14.32%
MSCI WORLD (^990100-USD-STRD)
0.88%

1-Year Return

NEU.WA
17.85%
MSCI WORLD (^990100-USD-STRD)
8.70%

3-Year Return

NEU.WA
5.96%
MSCI WORLD (^990100-USD-STRD)
33.45%

5-Year Return

NEU.WA
69.88%
MSCI WORLD (^990100-USD-STRD)
83.62%

Compare To: NEU.WA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NEU.WA

View More

Valuation Measures

As of 5/6/2025
  • Market Cap

    3.33B

  • Enterprise Value

    3.52B

  • Trailing P/E

    20.57

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    3.03

  • Enterprise Value/Revenue

    0.29

  • Enterprise Value/EBITDA

    8.46

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.22%

  • Return on Assets (ttm)

    3.21%

  • Return on Equity (ttm)

    13.90%

  • Revenue (ttm)

    12.61B

  • Net Income Avi to Common (ttm)

    154.24M

  • Diluted EPS (ttm)

    35.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    143.94M

  • Total Debt/Equity (mrq)

    52.55%

  • Levered Free Cash Flow (ttm)

    -181.95M

Research Analysis: NEU.WA

View More

People Also Watch